[Invasive diagnosis of portal hypertension in cirrhosis: a critical evaluation of the hepatic venous pressure gradient measurement]
- PMID: 16435504
- DOI: 10.1016/s0399-8320(05)88171-0
[Invasive diagnosis of portal hypertension in cirrhosis: a critical evaluation of the hepatic venous pressure gradient measurement]
Abstract
Portal hypertension is defined by an increased pressure gradient between the portal vein and the inferior vena cava (N < 5 mmHg). The most commonly used technique to assess the severity of portal hypertension is the catheterization of one hepatic vein with measurement of pressures in a free position and in a wedged position using preferably a balloon catheter. The hepatic venous pressure gradient is calculated by the difference between both pressures. In most cirrhotic processes, venous pressure gradient gives a good evaluation of portal hypertension however, portal vein pressure can be higher than wedged hepatic venous pressure, particularly in presence of an increased pre-sinusoidal resistance. In such cases, a direct access to portal vein might be needed to assess the severity of portal hypertension. For an accurate interpretation of the hepatic venous pressure gradient, several strict criteria must be followed; otherwise the validity of measurements might be seriously questioned. Hepatic venous pressure gradient has been used as a prognostic marker of portal hypertension, particularly for the occurrence of bleeding from gastrophageal varices which almost never occur below a threshold value of 12 mmHg. However, the prognostic value of the hepatic venous pressure gradient for survival is still a controversial matter On the other hand, the use of hepatic venous pressure gradient has been proposed to monitor the pharmacological treatment of portal hypertension and it is generally accepted that reaching a same threshold value of 12 mmHg should almost completely abolish the risk of first or recurrent variceal bleeding. A large number of studies have also reported that a 20% hepatic venous pressure gradient decrease should be considered as a significant response to therapy, the risk of the first or recurrent bleeding being significantly reduced in responders. But again there are conflicting results.
Similar articles
-
Hepatic venous pressure gradient measurement: time to learn!Indian J Gastroenterol. 2008 Mar-Apr;27(2):74-80. Indian J Gastroenterol. 2008. PMID: 18695309 Review.
-
Intrahepatic veno-venous collateralization and misrepresentative hepatic venous pressure gradients in children.Pediatr Radiol. 2020 Oct;50(11):1579-1586. doi: 10.1007/s00247-020-04751-9. Epub 2020 Jun 24. Pediatr Radiol. 2020. PMID: 32583092
-
Free Hepatic Vein Pressure Is Not Useful to Calculate the Portal Pressure Gradient in Cirrhosis: A Morphologic and Hemodynamic Study.J Vasc Interv Radiol. 2016 Aug;27(8):1130-7. doi: 10.1016/j.jvir.2016.03.028. Epub 2016 Jun 7. J Vasc Interv Radiol. 2016. PMID: 27212121
-
Comparison of hepatic venous pressure gradient and endoscopic grading of esophageal varices.World J Gastroenterol. 2016 Mar 21;22(11):3212-9. doi: 10.3748/wjg.v22.i11.3212. World J Gastroenterol. 2016. PMID: 27003998 Free PMC article.
-
Assessment of the agreement between wedge hepatic vein pressure and portal vein pressure in cirrhotic patients.Dig Liver Dis. 2005 Aug;37(8):601-8. doi: 10.1016/j.dld.2005.02.009. Dig Liver Dis. 2005. PMID: 15908290 Review.
Cited by
-
Assessment of intrahepatic blood flow by Doppler ultrasonography: relationship between the hepatic vein, portal vein, hepatic artery and portal pressure measured intraoperatively in patients with portal hypertension.BMC Gastroenterol. 2011 Jul 19;11:84. doi: 10.1186/1471-230X-11-84. BMC Gastroenterol. 2011. PMID: 21767412 Free PMC article.
-
Peculiar characteristics of portal-hepatic hemodynamics of alcoholic cirrhosis.World J Gastroenterol. 2014 Jul 7;20(25):8005-10. doi: 10.3748/wjg.v20.i25.8005. World J Gastroenterol. 2014. PMID: 25009370 Free PMC article. Review.
-
Sonographic gallbladder wall thickness measurement and the prediction of esophageal varices among cirrhotics.World J Hepatol. 2023 Feb 27;15(2):216-224. doi: 10.4254/wjh.v15.i2.216. World J Hepatol. 2023. PMID: 36926231 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources